(lp0
S'Atossa Genetics Inc  Should Continue To Run This Quarter Insider Financial - Feb 9, 2017 Atossa Genetics Inc  is lighting up scanners everywhere, having scored gains of more than 20% mid week and looking set to pick up further strength as the week draws to a close.'
p1
aS"Ambitious Atossa Genetics Going After Two Breast Cancer Blockbusters Seeking Alpha - Dec 10, 2015 That technology is now licensed to Atossa Genetics , a small biotech about 1/7900th of Abbvie's size. Atossa has licensed a gel reformulation of AstraZeneca's  Nolvadex, better known as generic tamoxifen. Tamoxifen is the most popular&nbsp;..."
p2
aS"What Type of Consensus Views Analysts hold about Atossa Genetics Inc.'s (ATOS ... Hot Stocks Point - 18 hours ago USA based company, Atossa Genetics Inc. 's latest closing price distance was -70.54% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at -51.22% and -35.28% compared with the 20 Day Moving&nbsp;...Earnings And Analyst Opinion Offer Spending Insights: Atossa Genetics Inc ... - Post AnalystThe Atossa Genetics  Given Daily News Sentiment Rating of 0.31 - Petro Global News 24"
p3
aS'Atossa Genetics Inc. ATOS  Wall Street Journal - Oct 2, 2012 News Atossa Genetics Inc.ATOS. Significant News Only. 04/04/17; Press Release. Atossa Genetics Enrolls First Cohort of Eight Subjects in Endoxifen Study.'
p4
aS"Drilling Down Into Atossa Genetics Inc.  StockNewsJournal - Apr 14, 2017 Atossa Genetics Inc.  is an interesting player in the Healthcare space, with a focus on Diagnostic Substances. The stock has been active on the tape, currently trading at $0.63, down from yesterday's close by -9.69%.Watch-list Street Stock: Atossa Genetics Inc.'s  stock price is at $0.63 ... - WsNews 4investorsAtossa Genetics  Given Daily News Sentiment Rating of 0.31 - Sports Perspectives"
p5
aS'Atossa Genetics Closes Public Offering MarketWatch - Apr 3, 2017 SEATTLE, WA, Apr 03, 2017  -- SEATTLE, WA-- - Atossa Genetics, Inc. ATOS, -0.27% today announced the closing of its previously announced underwritten public offering with gross proceeds to Atossa&nbsp;...Atossa Genetics Enrolls First Cohort of Eight Subjects in Endoxifen Study - Yahoo FinanceAtossa Genetics Inc. : Analysts bet a 130.26 percent change in price - Post Analyst'
p6
aS'Analysts Reviews on: Atossa Genetics, Inc.  TRA - 22 hours ago Atossa Genetics, Inc.  ended its last session at $0.63 by Declining -9.69%. The company currently has an average volume of 185.93 Million.'
p7
aS"Atossa Genetics: Spotty Track Record And Short On Cash Seeking Alpha  - Feb 26, 2015 Atossa Genetics  went up over 40% in early trading when it announced Henry Schein will offer Atossa Genetics' FullCYTE Breast Aspirator on Feb 26th, 2015. Traders and investors have been repetitively trapped by this type of trivial news&nbsp;..."
p8
aS'Atossa Genetics Inc  Explodes Up The Charts Insider Financial - Feb 19, 2016 Shares of Atossa Genetics Inc  have exploded up the charts recently on news of insider buying and optimism for upcoming clinical trial updates.'
p9
aS'Atossa Genetics  Stock Declines Today on Heavy Trading Volume TheStreet.com - Dec 29, 2014 NEW YORK  -- Shares of Atossa Genetics  are down 8.5% to $1.72 on heavy trading volume after the healthcare company, focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast&nbsp;...'
p10
a.